Georges Gemayel

Insider Reports History

Entity
Individual
Location
550 Hills Drive, Bedminster, NJ
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Georges Gemayel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. Director Common Stock 13.3K $483K $36.30 Nov 8, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Restricted Stock Unit 0 $0 $29.06 Feb 23, 2024 Direct
Disc Medicine, Inc. Director Stock Option (Right to Buy) 10K Jun 12, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. Director Director Stock Option (Right to Buy) 0 Nov 8, 2024 Direct

Insider Reports Filed by Georges Gemayel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 8, 2024 3 -$268K 4 Nov 12, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 7, 2024 3 -$358K 4 Nov 8, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Sep 13, 2024 4 -$320K 4 Sep 17, 2024 Director
IRON Disc Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 2 $0 4 Feb 27, 2024 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 2 $0 4 Feb 26, 2024 Director
IRON Disc Medicine, Inc. Jun 9, 2023 1 $0 4 Jun 9, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
IRON Disc Medicine, Inc. Dec 29, 2022 1 $0 4 Jan 3, 2023 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4 Feb 24, 2022 Director
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 19, 2022 2 $0 4 Feb 23, 2022 Director
IRON Gemini Therapeutics, Inc. /DE Jan 3, 2022 1 $0 4 Jan 5, 2022 Executive Chair of the Board, Director
IRON Gemini Therapeutics, Inc. /DE Nov 15, 2021 2 $0 4 Nov 16, 2021 Executive Chair of the Board of Directors, Director